ZNF676
geneOn this page
Summary
ZNF676 (zinc finger protein 676, HGNC:20429) is a protein-coding gene on chromosome 19p12, encoding Zinc finger protein 676 (Q8N7Q3). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus.
Source: NCBI Gene 163223 — RefSeq curated summary.
At a glance
- GWAS associations: 3
- Clinical variants (ClinVar): 108 total
- MANE Select transcript:
NM_001001411
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:20429 |
| Approved symbol | ZNF676 |
| Name | zinc finger protein 676 |
| Location | 19p12 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000196109 |
| Ensembl biotype | protein_coding |
| Entrez | 163223 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000397121, ENST00000650058, ENST00000651839, ENST00000904872
RefSeq mRNA: 1 — MANE Select: NM_001001411
NM_001001411
CCDS: CCDS42539
Canonical transcript exons
ENST00000395385 — 0 exons
Expression profiles
Bgee: expression breadth ubiquitous, 119 present calls, max score 83.06.
FANTOM5 (CAGE): breadth broad, TPM avg 0.8813 / max 456.5353, expressed in 185 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180249 | 0.8034 | 180 |
| 180248 | 0.0779 | 29 |
Top tissues by expression
129 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 83.06 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 80.86 | gold quality |
| thyroid gland | UBERON:0002046 | 70.35 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 69.48 | gold quality |
| right uterine tube | UBERON:0001302 | 69.28 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 68.59 | gold quality |
| smooth muscle tissue | UBERON:0001135 | 67.94 | gold quality |
| islet of Langerhans | UBERON:0000006 | 66.92 | gold quality |
| left coronary artery | UBERON:0001626 | 66.74 | gold quality |
| heart left ventricle | UBERON:0002084 | 66.69 | gold quality |
| right coronary artery | UBERON:0001625 | 66.67 | gold quality |
| heart | UBERON:0000948 | 66.42 | gold quality |
| apex of heart | UBERON:0002098 | 66.26 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 66.08 | gold quality |
| body of uterus | UBERON:0009853 | 66.07 | gold quality |
| right atrium auricular region | UBERON:0006631 | 65.95 | gold quality |
| ascending aorta | UBERON:0001496 | 65.68 | gold quality |
| thoracic aorta | UBERON:0001515 | 65.68 | gold quality |
| testis | UBERON:0000473 | 65.57 | gold quality |
| fallopian tube | UBERON:0003889 | 65.24 | gold quality |
| omental fat pad | UBERON:0010414 | 64.82 | gold quality |
| pancreas | UBERON:0001264 | 64.76 | gold quality |
| calcaneal tendon | UBERON:0003701 | 64.29 | gold quality |
| myometrium | UBERON:0001296 | 63.90 | gold quality |
| body of pancreas | UBERON:0001150 | 63.87 | gold quality |
| left testis | UBERON:0004533 | 63.84 | gold quality |
| right testis | UBERON:0004534 | 63.77 | gold quality |
| left uterine tube | UBERON:0001303 | 63.42 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 63.24 | gold quality |
| lower esophagus | UBERON:0013473 | 63.21 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6142 | no | 10.07 |
| E-ANND-3 | no | 2.21 |
Regulation
Is transcription factor: yes
JASPAR motifs
| Motif | Name | Family |
|---|---|---|
| MA2569.1 | ZNF676 | More than 3 adjacent zinc fingers |
JASPAR matrix evidence (PMIDs): PMID:39605368
miRNA regulators (miRDB)
74 targeting ZNF676, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3925-3P | 100.00 | 69.95 | 1237 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-3064-3P | 100.00 | 70.09 | 1254 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-1252-5P | 100.00 | 69.80 | 2774 |
| HSA-MIR-656-3P | 100.00 | 72.15 | 2788 |
| HSA-MIR-12121 | 99.99 | 66.64 | 255 |
| HSA-MIR-511-3P | 99.99 | 68.85 | 1467 |
| HSA-MIR-4715-3P | 99.98 | 66.03 | 670 |
| HSA-MIR-548AN | 99.97 | 70.91 | 2817 |
| HSA-MIR-146A-5P | 99.96 | 68.93 | 988 |
| HSA-MIR-146B-5P | 99.96 | 69.13 | 977 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-MIR-6845-3P | 99.94 | 66.88 | 1439 |
| HSA-MIR-7153-5P | 99.94 | 68.89 | 1006 |
| HSA-MIR-6809-3P | 99.91 | 71.45 | 3814 |
| HSA-MIR-7162-3P | 99.89 | 68.16 | 1682 |
| HSA-MIR-548E-5P | 99.89 | 72.73 | 4486 |
| HSA-MIR-200A-5P | 99.76 | 69.10 | 949 |
| HSA-MIR-200B-5P | 99.76 | 69.05 | 948 |
| HSA-MIR-4755-5P | 99.71 | 70.34 | 2716 |
| HSA-MIR-5006-3P | 99.71 | 70.26 | 2728 |
| HSA-MIR-580-3P | 99.67 | 69.23 | 1841 |
| HSA-MIR-10393-5P | 99.65 | 68.01 | 1368 |
| HSA-MIR-1251-3P | 99.64 | 67.21 | 1408 |
Literature-anchored findings (GeneRIF, showing 2)
- Genome-wide meta-analysis points to CTC1 and ZNF676 as genes regulating telomere homeostasis in humans. (PMID:23001564)
- Transcriptome wide association study results identified two novel genes as statistically significantly associated with nonobstructive azoospermia susceptibility: PILRA and ZNF676. (PMID:29202958)
Cross-species orthologs
0 orthologs
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein 676 — Q8N7Q3 (reviewed: Q8N7Q3)
All UniProt accessions (2): Q8N7Q3, A0A3B3ITU2
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_001001411* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050758 | Znf_C2H2-type | Family |
Pfam: PF00096, PF13465
UniProt features (23 total): zinc finger region 15, sequence variant 3, sequence conflict 3, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8N7Q3-F1 | 72.69 | 0.24 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 42 (showing top):
chr19p12, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, ZWANG_TRANSIENTLY_UP_BY_2ND_EGF_PULSE_ONLY, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, MIR23A_3P_MIR23B_3P, MIR23C, MIR6809_3P, MIR6833_3P, MIR6873_3P, MIR4768_5P, MIR892C_5P, MIR3925_3P, MIR3064_3P, MIR511_3P, MIR4776_3P
GO Biological Process (2): regulation of DNA-templated transcription (GO:0006355), regulation of transcription by RNA polymerase II (GO:0006357)
GO Molecular Function (5): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription by RNA polymerase II | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
322 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF676 | CTC1 | Q2NKJ3 | 697 |
| ZNF676 | DHX35 | Q9H5Z1 | 667 |
| ZNF676 | ACYP2 | P14621 | 667 |
| ZNF676 | STN1 | Q9H668 | 663 |
| ZNF676 | PXK | Q7Z7A4 | 604 |
| ZNF676 | ALG1L2 | C9J202 | 576 |
| ZNF676 | DCAF4 | Q8WV16 | 571 |
| ZNF676 | OR2G6 | Q5TZ20 | 474 |
| ZNF676 | METTL21C | Q5VZV1 | 465 |
| ZNF676 | TERT | O14746 | 446 |
| ZNF676 | MEIS3 | Q99687 | 443 |
| ZNF676 | RTEL1 | Q9NZ71 | 436 |
| ZNF676 | CFAP57 | Q96MR6 | 418 |
| ZNF676 | DNAH11 | Q96DT5 | 409 |
| ZNF676 | A0A087WVV2 | A0A087WVV2 | 399 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| ECE1 | ZNF676 | psi-mi:“MI:0915”(physical association) | 0.370 |
| TP63 | HNRNPR | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (1): ZNF676 (Affinity Capture-MS)
ESM2 similar proteins: A2VDQ7, A6NK75, A6NN14, A6NNF4, A8MQ14, A8MTY0, A8MXY4, B7Z6K7, E9QAG8, O43345, O75290, O75373, O75437, P0CJ79, P10751, P17017, P17019, P17035, P17038, P18749, P35789, P51522, Q03923, Q03938, Q05481, Q14585, Q3SYV7, Q4V348, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6P5C7, Q6ZN08, Q6ZN57, Q6ZR52, Q86V71, Q86XN6, Q8IYB9, Q8N7Q3
Diamond homologs: A0A1W2PQL4, A6NK75, A6NN14, A6NNF4, A6NP11, A8MQ14, A8MTY0, A8MUV8, A8MXY4, B4DX44, B4DXR9, E9PYI1, O14628, O43345, O75290, O75346, O75373, O75437, O95780, P0CB33, P0DKX0, P0DPD5, P16373, P17019, P17038, P21506, P35789, P52736, P52738, P52744, Q03923, Q03924, Q03936, Q03938, Q05481, Q14586, Q14593, Q14929, Q15928, Q3KNS6
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
108 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 87 |
| Likely benign | 11 |
| Benign | 1 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
498 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:22196430:AGGAC:A | donor_gain | 1.0000 |
| 19:22181582:TATAA:T | acceptor_gain | 0.9900 |
| 19:22181584:TAA:T | acceptor_gain | 0.9900 |
| 19:22181587:C:CC | acceptor_gain | 0.9900 |
| 19:22181583:ATAA:A | acceptor_gain | 0.9800 |
| 19:22181584:TAAC:T | acceptor_loss | 0.9700 |
| 19:22181587:CT:C | acceptor_loss | 0.9700 |
| 19:22181588:T:C | acceptor_loss | 0.9700 |
| 19:22193107:AATAC:A | acceptor_loss | 0.9600 |
| 19:22193108:ATACC:A | acceptor_loss | 0.9600 |
| 19:22193109:TACCT:T | acceptor_loss | 0.9600 |
| 19:22193110:ACCT:A | acceptor_loss | 0.9600 |
| 19:22193111:CC:C | acceptor_loss | 0.9600 |
| 19:22193113:T:C | acceptor_loss | 0.9600 |
| 19:22196598:AC:A | donor_gain | 0.9600 |
| 19:22196599:CC:C | donor_gain | 0.9600 |
| 19:22196639:T:A | donor_gain | 0.9600 |
| 19:22193114:G:C | acceptor_loss | 0.9500 |
| 19:22196429:CAGG:C | donor_gain | 0.9500 |
| 19:22196430:AGGA:A | donor_gain | 0.9500 |
| 19:22196592:ATTCT:A | donor_loss | 0.9400 |
| 19:22196594:TCTCA:T | donor_loss | 0.9400 |
| 19:22196595:CTCAC:C | donor_loss | 0.9400 |
| 19:22196596:T:TA | donor_loss | 0.9400 |
| 19:22196597:CA:C | donor_loss | 0.9400 |
| 19:22196599:C:G | donor_loss | 0.9400 |
| 19:22181585:AA:A | acceptor_gain | 0.9300 |
| 19:22193010:ACCT:A | donor_loss | 0.9300 |
| 19:22193011:CCTA:C | donor_loss | 0.9300 |
| 19:22193012:CTAC:C | donor_loss | 0.9300 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000013190 (19:22244216 G>A), RS1000077987 (19:22208440 A>G), RS1000151155 (19:22208208 G>T), RS1000161076 (19:22253059 C>A), RS1000187492 (19:22213981 T>A,C,G), RS1000222285 (19:22209325 A>C,G,T), RS1000261703 (19:22248985 C>T), RS1000276452 (19:22252787 A>G), RS1000351697 (19:22218644 G>A,T), RS1000360572 (19:22258083 G>C), RS1000365660 (19:22183439 G>A), RS1000380326 (19:22254462 A>T), RS1000428774 (19:22260064 G>C,T), RS1000489110 (19:22244095 G>A,C), RS1000501492 (19:22254429 G>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
3 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST000669_1 | Telomere length | 2.000000e-06 |
| GCST001697_1 | Telomere length | 1.000000e-08 |
| GCST008554_7 | Atorvastatin-induced myopathy | 3.000000e-06 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
18 total (human), top 18 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| enzacamene | decreases expression | 1 |
| pentanal | decreases expression | 1 |
| Resveratrol | affects cotreatment, decreases expression | 1 |
| Amiodarone | increases expression | 1 |
| Copper | affects cotreatment, decreases expression | 1 |
| Dimethoate | increases expression | 1 |
| Endosulfan | decreases expression | 1 |
| Estradiol | increases expression | 1 |
| Iopanoic Acid | increases expression | 1 |
| Methimazole | increases expression | 1 |
| Methoxychlor | increases expression | 1 |
| Methylmercury Compounds | increases expression | 1 |
| Propylthiouracil | increases expression | 1 |
| Tetrachlorodibenzodioxin | decreases expression | 1 |
| Triiodothyronine | decreases expression, increases expression | 1 |
| Aflatoxin B1 | increases expression | 1 |
| Cadmium Chloride | increases expression | 1 |
| Iodoacetic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): myopathy